FOSPHENYTOIN SODIUM
Generic: FOSPHENYTOIN SODIUM
Hikma Pharmaceuticals USA Inc.Manufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
FOSPHENYTOIN SODIUMActive Substance
2007-08-06Original Approval
FOSPHENYTOIN SODIUM is FDA application ANDA077989, sponsored by HIKMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2012-04-13
Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial, packaged in 10-count Presence of Particulate Matter: This product is being recalled due to the discovery of particles in
Class II2012-04-13
Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x Presence of Particulate Matter: This product is being recalled due to the discovery of particles in
Top Reported Reactions
1
DRUG INEFFECTIVE
122 reports
2
OFF LABEL USE
69 reports
3
STATUS EPILEPTICUS
46 reports
4
CARDIAC ARREST
42 reports
5
HYPOTENSION
40 reports
6
PYREXIA
35 reports
7
SEIZURE
32 reports
8
BLOOD PRESSURE DECREASED
27 reports
9
DRUG INTERACTION
23 reports
10
RESPIRATORY DEPRESSION
23 reports